5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexyl-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide
C22H21N5O2S2 — CID 154645900
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexyl-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide
5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexyl-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide (PubChem CID 154645900) has the molecular formula C22H21N5O2S2 and a molecular weight of 451.58 g/mol. Its IUPAC name is 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexyl-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide.
Molecular Properties
| Compound Name | 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexyl-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide |
|---|---|
| PubChem CID | 154645900 |
| Molecular Formula | C22H21N5O2S2 |
| Molecular Weight | 451.58 g/mol |
| Exact Mass | 451.11 |
| IUPAC Name | 5-(2-acetamido-1,3-benzothiazol-6-yl)-N-cyclohexyl-[1,2]thiazolo[5,4-b]pyridine-3-carboxamide |
| SMILES | CC(=O)Nc1nc2ccc(-c3cnc4snc(C(=O)NC5CCCCC5)c4c3)cc2s1 |
| InChI | InChI=1S/C22H21N5O2S2/c1-12(28)24-22-26-17-8-7-13(10-18(17)30-22)14-9-16-19(27-31-21(16)23-11-14)20(29)25-15-5-3-2-4-6-15/h7-11,15H,2-6H2,1H3,(H,25,29)(H,24,26,28) |
| InChIKey | PQWZQWDYOJKSQC-UHFFFAOYSA-N |
| XLogP | 4.99 |
| TPSA | 96.87 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 451.58 |
| LogP ≤ 5 | 4.99 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154645900 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.